UIC Transplant Pharmacotherapy Team
@UICTXPRX
Followers
300
Following
3K
Media
70
Statuses
1K
One of Nation's First Transplant Pharmacotherapy Team. Serving Transplant Recipients and Their Families since 1970s. Changing Lives. Striving for Excellence!
Univ of Illinois at Chicago
Joined June 2022
I am being asked by a CRO to provide rationale of why an acute bilateral pulmonary embolism on a clinical trial would be a clinically important event! The biggest problem in clinical research is the increasing number of involved people who don’t understand clinical medicine.
9
11
120
August 2025 issue of @TransplantJrnl ! This issue highlights: ◼Xenotransplantation Position Statements ◼Imlifidase Guidelines ◼Unmet Educational and Psychological Needs After Graft Loss ◼Understanding Gene Regulation in Organ Transplantation https://t.co/55buCjTD2w
0
4
15
Are we discarding transplantable livers too soon? A new study shows that nonbiopsy assessments of donor liver fat (steatosis) are often too conservative — leading to up to 17% unnecessary liver discards. #TXPforAll #LiverTransplantation
https://t.co/ry2PSJv8wQ
0
8
9
The 2024 ILTS-ILCA consensus recommendations for liver transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. @_ILTS_
https://t.co/EVtgzbC4vc
journals.lww.com
Center-level guidelines and practices in transplant oncology significantly vary across the world, leading to debate regarding the best course of treatment for this patient population. An internatio...
0
44
65
Large prospective study evaluates TruGraf & Viracor-TRAC for noninvasive kidney rejection diagnosis. While TruGraf & TRAC failed validation for rejection overall, TRAC shows promise for diagnosing AMR/mixed rejection with DSA in dysfunctional grafts https://t.co/0QFxz10G4r
1
5
14
Check out our new manuscript sharing @MayoClinic Arizona’s clinical experience with NMP. Compared to SCS, NMP was associated w ⬇️ Early allograft dysfunction ⬇️ Blood transfusions, OR time, AKI ⬇️ Length of stay and readmissions ⬆️ Graft and patient survival @MathurAmitK
Normothermic machine perfusion improved graft and patient survival, reduced early allograft dysfunction, and lowered hospital resource use compared to static cold storage. https://t.co/Tbm1GHW4Qk
@ChiZhang_MD
1
15
48
🚨 New publication 🚨 Angiotensin II as a Vasopressor for Perioperative Hypotension in Solid Organ Transplant https://t.co/9NX4x1pFZ4
#mdpibiomedicines via @Biomed_MDPI
@UICTXPRX @UICPhPr
mdpi.com
During the perioperative period of transplantation, patients experience hypotension secondary to the side effects of anesthesia, surgical stress, inflammatory triggering, and intraoperative fluid...
0
1
4
IgA Nephropathy (IgAN): Treatment Pillars ca. 2024 from @MDPIOpenAccess @IgAN_JBarratt @DanaRizk1 #Nephpearls 📌 Optimal supportive care 1⃣ Mitigating consequences of ongoing nephron loss 2⃣ Halting glomerular inflammation 3⃣ Reducing production of Gd-IgA1 4⃣ Stopping
1
88
202
Functions and risks of aging-related diseases change nonlinearly across the human lifespan https://t.co/aGA6mpgjRq
nature.com
Nature Aging - Understanding the molecular changes underlying aging is important for developing biomarkers and healthy aging interventions. In this study, the authors used comprehensive multi-omics...
0
1
1
#TBT to this week's featured top downloaded paper from 2022: Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review #Transplantation #Med
https://t.co/AeK6UgYIJO
0
8
18
Hi everyone! Check out the July issue featuring as cover the work from @Esteban_CG_ @AlexandreLoupy @olivieraubert_ et al describing the use of NGS in kidney transplant biopsies to identify molecular signatures of rejection👉 https://t.co/3RRCK1GN3v
@ESOTtransplant @ParisTxGroup
0
14
28
Cohosts @mannonmom and Josh Levitsky are joined by Maria Alejandra Mendoza to discuss key articles of the August issue of American Journal of Transplantation. #AJTHighlights
https://t.co/wLI9Q5Ewbo
0
5
18
Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism-related vascular thrombosis with microvascular injury and its consequences - Kidney International
kidney-international.org
Cholesterol crystal embolism (CCE) implies immunothrombosis, tissue necrosis, and organ failure but no specific treatments are available. As CCE involves complement activation, we speculated that...
0
4
19
The survey results show pharmacists were more likely to make any adjustments to GDMT than internists and cardiologists. OPEN ACCESS https://t.co/w78ru8b5bL
@accpcardprn
0
4
11
The new generation of B cell–targeting therapies for the treatment of autoimmune kidney diseases Watch the author present his paper here: 🆓 https://t.co/J43LJMcoyk
0
31
73
"Genetic versus self-reported African ancestry of the recipient and neighborhood predictors of kidney transplantation outcomes in 2 multiethnic urban cohorts" by Zanoni et al. https://t.co/VAJGGVZvMy
0
2
8
Following Dr. Whittier’s discussion on TRF Budesonide at #GlomConHawaii , explore this visual abstract that captures the key clinical trial outcomes—reductions in proteinuria and stable kidney function. @GlomCon @TWhittier_RUSH
2
9
24
Just after a powerful lupus nephritis session by Dr. @BradRovin at #GlomConHawaii2024. These unique LN cases of non-ESKD calciphylaxis really hit close to home—eye-opening data and outcomes captured in this visual abstract. @GlomCon @GlomConILA
1
15
32
Clinical Management of C3/TMA 🗣️ Dr. Carla Nester 🩺 When to suspect complement mediated TMA? 🔵 Family Hx 🔵Prior personal hx 🔵Pathogenic variant in a classic gene 🩺 Why are 🧬 important? 🔵Diagnosis 🔵Help to decide what to do #GlomConHawaii
0
9
27